Targeted therapy for osteosarcoma: a review

S Li, H Zhang, J Liu, G Shang - Journal of Cancer Research and Clinical …, 2023 - Springer
Background Osteosarcoma is a common primary malignant tumour of the bone that usually
occurs in children and adolescents. It is characterised by difficult treatment, recurrence and …

[HTML][HTML] Resveratrol and other natural oligomeric stilbenoid compounds and their therapeutic applications

CG Duta-Bratu, GM Nitulescu, DP Mihai, OT Olaru - Plants, 2023 - mdpi.com
The use of natural compounds as an alternative to synthetic molecules has become a
significant subject of interest in recent decades. Stilbenoids are a group of phenolic …

[HTML][HTML] Anti-cancer activity of phytochemicals targeting hypoxia-inducible factor-1 alpha

BD Yun, SW Son, SY Choi, HJ Kuh, TJ Oh… - International Journal of …, 2021 - mdpi.com
Hypoxia-inducible factor-1 alpha (HIF-1α) is overexpressed in cancer, leading to a poor
prognosis in patients. Diverse cellular factors are able to regulate HIF-1α expression in …

[HTML][HTML] Cancer-specific association between Tau (MAPT) and cellular pathways, clinical outcome, and drug response

M Callari, M Sola, C Magrin, A Rinaldi, M Bolis… - Scientific Data, 2023 - nature.com
Tau (MAPT) is a microtubule-associated protein causing common neurodegenerative
diseases or rare inherited frontotemporal lobar degenerations. Emerging evidence for non …

[HTML][HTML] Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma

R Huang, M Xu, W Guo, M Cheng, R Dong, J Tu… - Cancer Cell …, 2023 - Springer
Background Luteolin is an active ingredient in various traditional Chinese medicines for the
treatment of multiple tumors. However, the mechanisms of its inhibitory effect on …

[HTML][HTML] Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma

Y Xiang, Y Yang, J Liu, X Yang - Frontiers in Oncology, 2023 - frontiersin.org
Osteosarcoma (OS) is a primary malignant bone tumor that occurs in children and
adolescents, and the PI3K/AKT pathway is overactivated in most OS patients. MicroRNAs …

[HTML][HTML] Crosstalk between autophagy and inflammatory processes in cancer

EJ Lee, HJ Kim, MS Choi, JE Chang - Life, 2021 - mdpi.com
Inflammation is an adaptive response to tissue injury, which is a critical process in order to
restore tissue functionality and homeostasis. The association between inflammation and …

[HTML][HTML] Design, synthesis, and biological evaluation of tetrahydroquinolinones and tetrahydroquinolines with anticancer activity

M Ryczkowska, N Maciejewska, M Olszewski… - Scientific Reports, 2022 - nature.com
Colorectal cancer (CRC) is the most commonly diagnosed cancer in Europe and the United
States and the second leading cause of cancer related mortality. A therapeutic strategy used …

[HTML][HTML] Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma

P Zhang, K Xu, J Wang, J Zhang, H Quan - Bmc Cancer, 2021 - Springer
Purpose Osteosarcoma (OS) is a differentiation disease caused by the genetic and
epigenetic differentiation of mesenchymal stem cells into osteoblasts. OS is a common …

Enhancing Therapeutic Efficacy in Cancer Treatment: Integrating Nanomedicine with Autophagy Inhibition Strategies

N Walweel, O Aydin - ACS Omega, 2024 - ACS Publications
The complicated stepwise lysosomal degradation process known as autophagy is in charge
of destroying and eliminating damaged organelles and defective cytoplasmic components …